These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 33835386)
41. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263 [TBL] [Abstract][Full Text] [Related]
42. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19. Matsuzawa Y; Kimura K; Ogawa H; Tamura K Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498 [TBL] [Abstract][Full Text] [Related]
43. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
44. Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic. Perico L; Benigni A; Remuzzi G Curr Opin Nephrol Hypertens; 2021 Mar; 30(2):252-263. PubMed ID: 33395036 [TBL] [Abstract][Full Text] [Related]
45. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Oz M; Lorke DE; Kabbani N Pharmacol Ther; 2021 May; 221():107750. PubMed ID: 33275999 [TBL] [Abstract][Full Text] [Related]
46. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player. Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252 [TBL] [Abstract][Full Text] [Related]
47. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Oz M; Lorke DE Biomed Pharmacother; 2021 Apr; 136():111193. PubMed ID: 33461019 [TBL] [Abstract][Full Text] [Related]
48. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery. Lores E; Wysocki J; Batlle D Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725 [TBL] [Abstract][Full Text] [Related]
49. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019. Siri-Angkul N; Chattipakorn SC; Chattipakorn N J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575 [TBL] [Abstract][Full Text] [Related]
50. Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System. Pucci F; Bogaerts P; Rooman M Viruses; 2020 Nov; 12(12):. PubMed ID: 33265982 [TBL] [Abstract][Full Text] [Related]
51. The fight against COVID-19: Striking a balance in the renin-angiotensin system. Dean AQ; Bozza WP; Twomey JD; Luo S; Nalli A; Zhang B Drug Discov Today; 2021 Oct; 26(10):2214-2220. PubMed ID: 33865979 [TBL] [Abstract][Full Text] [Related]
52. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study. Lim JH; Cho JH; Jeon Y; Kim JH; Lee GY; Jeon S; Noh HW; Lee YH; Lee J; Chang HH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim SW Sci Rep; 2020 Nov; 10(1):20250. PubMed ID: 33219294 [TBL] [Abstract][Full Text] [Related]
53. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease. Menon R; Otto EA; Sealfon R; Nair V; Wong AK; Theesfeld CL; Chen X; Wang Y; Boppana AS; Luo J; Yang Y; Kasson PM; Schaub JA; Berthier CC; Eddy S; Lienczewski CC; Godfrey B; Dagenais SL; Sohaney R; Hartman J; Fermin D; Subramanian L; Looker HC; Harder JL; Mariani LH; Hodgin JB; Sexton JZ; Wobus CE; Naik AS; Nelson RG; Troyanskaya OG; Kretzler M Kidney Int; 2020 Dec; 98(6):1502-1518. PubMed ID: 33038424 [TBL] [Abstract][Full Text] [Related]
54. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565 [TBL] [Abstract][Full Text] [Related]
55. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Nicolau LAD; Magalhães PJC; Vale ML Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925 [TBL] [Abstract][Full Text] [Related]
56. In search of preventive strategies: novel high-CBD Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759 [TBL] [Abstract][Full Text] [Related]
57. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Steckelings UM; Sumners C Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709 [TBL] [Abstract][Full Text] [Related]
58. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic. Chamata Y; Jackson KG; Watson KA; Jauregi P Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769093 [TBL] [Abstract][Full Text] [Related]
59. Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system. Xu C; Chen Y; Yu J Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):1-11. PubMed ID: 35130610 [TBL] [Abstract][Full Text] [Related]
60. Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2. Sharma D; Sharma J; Singh A J Renin Angiotensin Aldosterone Syst; 2021; 2021():9939929. PubMed ID: 34285711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]